skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Role of posaconazole in the treatment of oropharyngeal candidiasis

Review

(1832) Views  (502) Full article downloads

Authors: Voichita Ianas, Kathryn R Matthias, Stephen A Klotz

Published Date June 2010 Volume 2010:3 Pages 45 - 51
DOI: http://dx.doi.org/10.2147/IDR.S10588

Voichita Ianas1, Kathryn R Matthias2, Stephen A Klotz1

1Section of Infectious Diseases and Department of Medicine, 2School of Pharmacy, University of Arizona, Tucson, Arizona, USA

Abstract: Posaconazole is the newest azole antifungal approved by the US Food and Drug Administration, and possesses a broad spectrum of activity against numerous yeasts and filamentous fungi. It is available as an oral suspension and is generally well tolerated by patients, but gastrointestinal absorption is sometimes inadequate and remains a clinical concern in treating deep-seated infections. It is used routinely and effectively for the prophylaxis of invasive fungal infections in immunosuppressed hosts and is an effective treatment of oropharyngeal candidiasis, including azole-resistant disease.

Keywords: posaconazole, azole, yeasts, filamentous fungi








Readers of this article also read:

Role of posaconazole in the management of oropharyngeal and esophageal candidiasis
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Optimal management of oropharyngeal and esophageal candidiasis in patients living with HIV infection
Prevention strategies for antimicrobial resistance: a systematic review of the literature
Drug resistance in community-acquired respiratory tract infections: role for an emerging antibacterial
Occult hepatitis B virus infection in Egyptian hemodialysis patients with or without hepatitis C virus infection
Boceprevir in the treatment of chronic hepatitis C virus infection
Management of oropharyngeal candidiasis with localized oral miconazole therapy: efficacy, safety, and patient acceptability
Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy
High prevalence of extended-spectrum β-lactamase-producing pathogens: results of a surveillance study in two hospitals in Ujjain, India
  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University